0.85
+0.0569(+7.19%)
Currency In USD
| Previous Close | 0.79 |
| Open | 0.79 |
| Day High | 0.85 |
| Day Low | 0.79 |
| 52-Week High | 2.48 |
| 52-Week Low | 0.63 |
| Volume | 615,894 |
| Average Volume | 996,848 |
| Market Cap | 17.65M |
| PE | 3.39 |
| EPS | 0.25 |
| Moving Average 50 Days | 1.21 |
| Moving Average 200 Days | 1.49 |
| Change | 0.06 |
If you invested $1000 in Longeveron Inc. (LGVN) since IPO date, it would be worth $11.45 as of September 09, 2025 at a share price of $0.849. Whereas If you bought $1000 worth of Longeveron Inc. (LGVN) shares 3 years ago, it would be worth $16.71 as of September 09, 2025 at a share price of $0.849.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Longeveron® Announces Key Leadership Updates
GlobeNewswire Inc.
Sep 03, 2025 8:05 PM GMT
Than Powell Than Powell, CBO, Longeveron Joshua Hare Joshua Hare, MD, FACC, FAHA, Co-Founder, Chief Science Officer and Chairman, Longeveron Than Powell, Chief Business Officer and head of business development, appointed Interim CEODr. Joshua
Longeveron® to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire Inc.
Aug 20, 2025 1:15 PM GMT
MIAMI, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related conditions, today ann
Longeveron Announces Closing Of Up To $17.5 Million Public Offering
GlobeNewswire Inc.
Aug 11, 2025 8:15 PM GMT
$5.0 million upfront with up to an additional $12.5 million of potential aggregate gross proceeds upon the exercise in full of short-term warrantsMIAMI, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a